Prosecution Insights
Prosecution Insights
6 pending office actions • 4 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (17%) |
| §103 only | 1 (17%) |
| §112 only | 2 (33%) |
| Multi-statute (no §101) | 2 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ELENISTE, PIERRE PAUL | 1 | 36.5% | +32.1% |
| BERTOGLIO, VALARIE E | 1 | 63.9% | +30.3% |
| PARISI, JESSICA DANIELLE | 1 | 77.1% | +32.4% |
| GOLDBERG, JEANINE ANNE | 1 | 45.9% | +40.9% |
| OGUNTADE, ELIZABETH BISOLA | 1 | 0.0% | +0.0% |
| WHALEY, PABLO S | 1 | 25.3% | +21.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17923672 | MEASUREMENT OF AFUCOSYLATED IGG FC GLYCANS AND RELATED COVID-19 TREATMENT METHODS | OGUNTADE, ELIZABETH BISOLA | 70d |
| 18563310 | METHOD FOR PRODUCING A POPULATION OF SYMMETRICALLY BARCODED TRANSPOSOMES | PARISI, JESSICA DANIELLE | — |
| 17768780 | USER INTERFACE AND BACKEND SYSTEM FOR PATHOGEN ANALYSIS | WHALEY, PABLO S | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18838647 | COMPOSITIONS AND METHODS FOR INHIBITING FSP1 | ELENISTE, PIERRE PAUL | — |
| 18563301 | METHODS FOR GENERATING PARVALBUMIN-POSITIVE INTERNEURONS | BERTOGLIO, VALARIE E | — |
| 18563310 | METHOD FOR PRODUCING A POPULATION OF SYMMETRICALLY BARCODED TRANSPOSOMES | PARISI, JESSICA DANIELLE | — |
| 18286685 | PROFILING CELL TYPES IN CIRCULATING NUCLEIC ACID LIQUID BIOPSY | GOLDBERG, JEANINE ANNE | — |
| 17768780 | USER INTERFACE AND BACKEND SYSTEM FOR PATHOGEN ANALYSIS | WHALEY, PABLO S | — |
| Art Unit | Apps |
|---|---|
| 1632 | 1 |
| 1682 | 1 |
| 1677 | 1 |
| 3619 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18838647 | COMPOSITIONS AND METHODS FOR INHIBITING FSP1 | ELENISTE, PIERRE PAUL | — | §112 | Non-Final OA | — | Pending | Aug 15, 2024 |
| 18563301 | METHODS FOR GENERATING PARVALBUMIN-POSITIVE INTERNEURONS | BERTOGLIO, VALARIE E | 1632 | §112 | Non-Final OA | — | Pending | Nov 21, 2023 |
| 18563310 | METHOD FOR PRODUCING A POPULATION OF SYMMETRICALLY BARCODED TRANSPOSOMES | PARISI, JESSICA DANIELLE | — | §102§103§112 | Non-Final OA | — | Pending | Nov 21, 2023 |
| 18286685 | PROFILING CELL TYPES IN CIRCULATING NUCLEIC ACID LIQUID BIOPSY | GOLDBERG, JEANINE ANNE | 1682 | §103 | Non-Final OA | — | Pending | Oct 12, 2023 |
| 17923672 | MEASUREMENT OF AFUCOSYLATED IGG FC GLYCANS AND RELATED COVID-19 TREATMENT METHODS | OGUNTADE, ELIZABETH BISOLA | 1677 | §103§112Other | Final Rejection | 70d | Pending | Nov 07, 2022 |
| 17768780 | USER INTERFACE AND BACKEND SYSTEM FOR PATHOGEN ANALYSIS | WHALEY, PABLO S | 3619 | §101§103§112 | Non-Final OA | — | Pending | Apr 13, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial